Explore Stanford technologies available for licensing:

Researchers at Stanford have developed a computational tool that enables the discovery of regenerative cells across all tissue types and novel targets in cancer.

Stanford researchers have designed a new type of reactor that uses magnetic induction instead of fossil fuel combustion to enable even distribution of high-grade heat for thermochemical processing.

Stanford researchers have developed tissue-based profiling by deep sequencing for detection of Minimal Residual Disease (MRD) by tracking patient-specific tumor mutations in post-chemotherapy tissue samples, enabling a highly sensitive, molecular-level assessment of residual c

Stanford researchers have developed an innovative ureteral stent (UreStent) which is designed to reduce stent-related complications by incorporating a distal tip with collapsible tube and a flexible retention cone to prevent urine reflux and bladder irritation, ensuring optima

Researchers at Stanford University have created a novel mitral valve annuloplasty ring that can be adjusted in size off-bypass in response to regurgitation.

Stanford researchers have designed a novel tricuspid annuloplasty ring that minimizes the risk of interrupting cardiac conduction during implantation.

Stanford researchers have developed ultra-wideband amplification of near infrared signals for the first time on a photonic integrated circuit.

Using their novel fabrication process, Stanford researchers have produced the world's first practical titanium-sapphire laser on a chip, transforming a once-exclusive tabletop technology to the microscale.

Stanford researcher's invivo studies find that combining PARP inhibitors with a hypoxia activated prodrug delays tumor growth.

Stanford researchers have developed a microfluidic system that uses optoelectronics for microdroplet manipulation to build synthetic oligonucleotides.

Researchers at Stanford have developed fusion proteins, containing ACE2 domain linked to a fragment of non-neutralizing anti-SARS-CoV-2 spike protein antibody, with a greater breadth of protection than previously described similar fusion proteins.

Researchers at Stanford have developed fully genetically-encodable lysosome-targeting chimeras which allow for the targeted delivery of various proteins into receiver cells.

Researchers at Stanford have developed methods for 3D printing and post-biomanufacturing of organoid slurries in a high yield stress matrix.

Stanford researchers have developed a novel fabrication method of high thermal conductivity 3D heat spreaders for semiconductor devices. Self-heating in the channel of semiconductor devices degrades device performance and shortens device lifetimes.

Current methods of genetically-engineered cells require precise integration of genetic material.